Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
(Daplusiran + tomligisiran) by GSK for Hepatitis B: Likelihood of Approval
(Daplusiran + tomligisiran) is under clinical development by GSK and currently in Phase II for Hepatitis B. According to GlobalData,...
Data Insights
(Daplusiran + tomligisiran) by GSK for Hepatitis D: Likelihood of Approval
(Daplusiran + tomligisiran) is under clinical development by GSK and currently in Phase II for Hepatitis D. According to GlobalData,...